v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2024
Jun. 30, 2023
Current assets:    
Cash and cash equivalents $ 186,072 $ 44,187
Accounts receivable 25,657 33,396
Inventory 35,842 276,202
Other current assets 187,225 92,726
Total current assets 434,796 446,511
Acquisition costs secured by promissory note 302,000
Indefinite lived intangible assets 1,333,271
Total assets 2,070,067 446,511
Current liabilities:    
Accounts payable and accrued liabilities 883,116 604,516
Convertible notes payable - net of discounts 2,990,249 1,491,719
Total current liabilities 4,124,112 2,198,111
Commitments and contingencies (Note 12)
Stockholders’ equity (deficit):    
Common stock, $0.001 par value, 200,000,000 shares authorized 127,907,407 and 123,587,968 issued and outstanding as of March 31, 2024 and June 30, 2023, respectively 127,907 123,588
Additional paid in capital 35,469,552 33,112,935
Accumulated deficit (37,651,522) (34,988,126)
Total Stockholders’ Equity (Deficit) (2,054,045) (1,751,600)
Total Liabilities and Stockholders’ Equity (Deficit) 2,070,067 446,511
Related party    
Current liabilities:    
Accounts payable and accrued liabilities - related party 250,747 101,876
Series A Preferred Stock    
Stockholders’ equity (deficit):    
Series of preferred stock 1 1
Series B Preferred Stock    
Stockholders’ equity (deficit):    
Series of preferred stock 2 2
Series C Preferred Stock    
Stockholders’ equity (deficit):    
Series of preferred stock 13
Series D Preferred Stock    
Stockholders’ equity (deficit):    
Series of preferred stock $ 2

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL